MSB 13.0% $1.31 mesoblast limited

Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS, page-18

  1. Al.
    198 Posts.
    lightbulb Created with Sketch. 114
    I remember sometime in 14/15 doing deep research on the GVHD and being impressed by remarkable ability of the product to save lives in this terrible complication arising from cancer treatment, never in a million years imagined a pandemic that could hit the world in this way. incredible to be an Australian at this point & especially of the legacy continuing to come from the enterprise of the Pratt family - supporters of MSB and the R&D tax rebates which have assisted to keep biotech discovery and development alive in a number of companies for many years eg AVH. Incredible, just imaging the numbers of people who will be cheered home as they leave hospital alive & well if the remarkable results to date are replicated in this trial
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
0.150(13.0%)
Mkt cap ! $1.490B
Open High Low Value Volume
$1.15 $1.33 $1.15 $25.26M 19.99M

Buyers (Bids)

No. Vol. Price($)
7 161000 $1.30
 

Sellers (Offers)

Price($) Vol. No.
$1.31 50400 2
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.